Marketwatch Aurobindo Pharma, Glenmark crack on USFDA observations Admin October 7, 2019 Aurobindo Pharma plunged 19% after USFDA flagged lack of good manufacturing practices at the Telangana plant. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
